Merck Mercuriadis’ Hipgnosis Songs Fund is already worth over $850m

The acquisitive company – which started trading on the London Stock Exchange (LSE) in July 2018 – is committed to undertaking a semi-annual valuation of its song portfolio, conducted by an independent valuer. According to that independent valuer, Hipgnosis’ unaudited Operative Net Asset Value (‘Operative NAV’) was 108.46 pence per Ordinary Share on September 30, 2019.

Source: Merck Mercuriadis’ Hipgnosis Songs Fund is already worth over $850m

Post a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Get the latest RightsTech news and analysis delivered directly in your inbox every week
We respect your privacy.